Kingston Story

Our names are Nick and Dina and a little over a year ago, we received the most devastating news of our lives when our
11-year-old son Kingston was diagnosed with cancer. In an instant, our joyful, active boy was thrust into a fight for his life.

Donors’ generosity has improved Kingston’s chances for survival.

Thanks to generous donors like you, our son has access to the latest treatments to help him fight this terrible disease. Donor-funded discoveries and clinical trials have paved the way for families like ours to receive leading-edge care, right here in Manitoba. Still, we have a long way to go before Kingston will be considered cancer-free. And before we can finally breathe a sigh of relief.

We are sharing Kingston’s story with you today in hopes that it will inspire you to support Manitobans with cancer this holiday season.

Kingston’s diagnosis came out of nowhere. He was an energetic young boy. And then, quite suddenly, he wasn’t. In the span of a week he went from playing soccer with friends to being tired and weak. His deteriorating health quickly led us to the emergency room.

Within hours of arriving at the hospital, Kingston was diagnosed with acute lymphocytic leukemia.

We were taken to the intensive care unit where Kingston would spend the next 10 days. Doctors discovered a 14-inch mass on the left side of his chest that left him struggling to breathe. This was the beginning of the fight for his life.

Kingston During Treatment_600x700

“It was heart-breaking to see him in a hospital bed, hooked up to so many machines.”

Kingston began chemotherapy that very night. For the next month he remained in hospital.

The fevers, exhaustion and nausea he experienced were extreme. He received chemotherapy multiple times a week. He endured painful lumbar punctures and regular doses of steroids.

We never left his side. And we never gave up hope — just as Kingston never stopped fighting.

Finally, after what felt like forever, Kingston was able to return home from the hospital.

Continued chemotherapy meant our lives remained unpredictable. The side effects were awful. Sometimes he couldn’t leave his room or eat for days. We’ve had too many hospital stays to count. Sometimes they were three days, four days, even 10 days long. We lost track of how many emergency room visits we made because his fever spiked dangerously. It was overwhelming.

“We had no idea, until Kingston’s illness, how much we would come to rely on the generosity of others to keep our son alive.”

By donating today, your gift will help discover new ways to treat blood cancers like the leukemia affecting our son. Without ongoing donor support, there is no guarantee discoveries will continue to be made and treatments will continue to advance. What would we do then? We can’t bear the thought.

We hope you will consider making a gift today to ensure children like Kingston continue to receive the leading-edge care they need.

Recently, Kingston completed the most intense part of his treatment, but his immune system was ravaged. His blood counts dropped so low that we had to wait for them to rise before he could move forward with the next phase of chemotherapy.

At the end of the summer, we learned he was strong enough to begin the next stage of his treatment. 

This would entail a series of daily medications that would continue to combat the cancer cells in his body.

While it’s still very difficult, this is the first time our family has felt anything close to our ‘normal’ life in over a year. After months of isolation from family and friends due to Kingston’s compromised immune system, we are now able to spend time with loved ones again.

I’m sure you can imagine the relief we feel.

Research is the cure for cancer.

Gifts from monthly donors help fund local cancer research. Vital research that may discover a new treatment for leukemias or other cancers. We hope you will consider joining this loyal group of donors with a monthly gift, knowing your partnership may enable important discoveries.

Kingston

There is still a long road ahead until Kingston completes his treatment in February 2026.

We are grateful to donors like you for advancing cancer care in Manitoba. 

Kingston is not out of the woods yet, and every step of the way brings new challenges. This is why it is so important to have your support.

Kingston’s resilience and determination motivates us to stay strong. For now, we are taking things day by day and trying to keep laughter in our home.

You give us hope.

Your gift this holiday season ensures that Manitoba kids like our son Kingston have the best chance to beat their cancer. You enable innovative treatments and enhanced patient care.

Your donation will once again make a difference for so many families like ours.

Our deepest gratitude,

Nick and Dina

Brenda’s Story

Like so many Manitobans, Brenda’s family has been deeply impacted by cancer. Their lives were changed forever when two of her sisters passed away from cancer within a short period of time. Today, 16 years later, Brenda herself is living with cancer and making the most of every day surrounded by the people she loves.

Brenda is thankful to donors like you, who support research at the Paul Albrechtsen Research Institute CancerCare Manitoba and the options your generosity has provided for her own cancer treatment. 

“When my sisters were sick, immunotherapy wasn’t an option for them. And today, it’s saving my life.”

Prior to her diagnosis, Brenda was focused on living a healthy lifestyle and intentionally trying to reduce her own risk of developing cancer. She maintained a healthy diet and walked daily with her husband Frank. 

In the fall of 2021, following an MRI, she was surprised to learn that there was a tumour on her lung. 

“I was completely caught off guard and in shock,” said Brenda. “At the time, both of my daughters were pregnant, and I was determined to get well and meet my grandchildren.”

Pictured: Brenda, her mother Pearl and sister Cindy

Following radiation, Brenda learned that she qualified for an immunotherapy treatment that would train her immune system to attack the cancer cells in her body.

Brenda + Frank treasure time with their grandchildren

It’s through donors’ continued support of cancer research that Manitobans like Brenda have access to new treatments and therapies that can give them more time with the people they love. 

The therapy was successful and today, Brenda’s cancer is stable.

Throughout her journey, Brenda’s family has always been her inspiration to keep going, stay healthy and not give up. 

“My family has been so deeply impacted by this horrible disease to which we have lost far too many. They have provided me with the strength and encouragement to fight. I am so thankful and appreciative to all the people who invest in programs and local research at CancerCare Manitoba, they are giving me hope for the future.”

Sandra’s Story

In 2017, Sandra was given one year to live. Today, seven years later she is travelling the world and living a full life thanks to the support of donors like you.

In the early fall of 2016, Sandra’s doctor referred her for a scan which showed spots on her lungs. Specialists reviewing her scans believed the suspected tumours were cancer, but Sandra would require surgery to confirm the diagnosis. In February of 2017, the surgery was completed, and pathology results later confirmed she had stage 3 lung cancer.

“When the results came back and they told me I had cancer, I didn’t believe it,” said Sandra. “It was really hard news to take in.” Sandra was told that even with treatment, she likely only had one year to live. She began chemotherapy but unfortunately had a negative reaction and had to stop.

Thanks to donor support of local cancer research, Sandra’s doctor was able to identify a different treatment option that would use her body’s natural immune system to specifically target the cancer cells in her body.

Sandra began immunotherapy, and for the next two years made the most of the time between treatments and scans by travelling the world. “Travelling is my way of looking forward. Now when I go in for my appointments, people don’t ask me how I am or how I’m feeling, they ask where I’ve been and where I’m going.”

In the fall of 2019, Sandra was able to take a break from treatment and for the following three years, the cancer remained stable. 

Then in 2023, one of her scans showed the development of new tumours on her lungs. Sandra qualified for a new type of radiation therapy developed thanks to years of donor-funded research in Manitoba.

The treatment offers qualified patients the opportunity to reduce their in-person visits and requires minimal targeted radiation appointments. 

Sandra at the La Scala Opera House in Milan in 2018 while undergoing immunotherapy treatment.

She required a second radiation treatment last March and today, thanks to donors’ support, Sandra is doing well and her cancer is stable. She continues with regular appointments and scans and spends a lot of her time doing what she loves – travelling.

Sandra has seen the progress and experienced the life-changing impact of donor-funded research at the Paul Albrechtsen Research Institute CancerCare Manitoba. Thanks to donor support more Manitobans like Sandra are living well with cancer. “Knowing I was only given a year or so to live, and here I am today…it’s pretty amazing that research can do this,” said Sandra.

Alyson’s Story – Email

"Living with lung cancer is a roller coaster of hope, anxiety and (sometimes) relief.”

These are the words of 66-year-old Alyson who over the last decade has experienced the highs and lows of a difficult cancer journey.

Today, Alyson is living with stage 4 lung cancer that has metastasized to her brain. And she will never be cured.

20240430245

However, thanks to the past support of donors, genetic testing enabled Alyson’s medical team to identify a daily anti-cancer medication that specifically targets the cancer cells in her body. As a result, Alyson’s cancer is currently stable and she has a better chance at a longer life with her partner, children and grandchildren.

When Alyson was diagnosed with stage 3 lung cancer in 2014 her life changed forever.

After chemotherapy and radiation failed to shrink the tumours, she had to undergo surgery to remove a portion of her lung. Fortunately, Alyson’s surgery was a success.

For three years Alyson was cancer free.

It was great. Life was wonderful and I was so grateful.”

 

In 2018 Alyson had blurred vision and began bumping into things. An urgent MRI revealed the cancer had returned.

This time, the tumours were on her brain. And it was inoperable.

“The news came just three weeks before my 60th birthday celebration. I was in shock.”

Alyson underwent a series of radiation treatments on her entire brain despite the dreaded side effects. She wanted more tomorrows with her loved ones and was willing to do whatever it took.

Manitobans’ generous investment in local research has enabled access to advanced genetic sequencing tests. Tests which led to highly targeted daily medication that’s keeping Alyson’s cancer stable. 

Alyson knows that one day, the cancer will start to resist the medication and begin to advance.  

When that day comes, she is hopeful that thanks to the investment in cancer research by people just like you, a new treatment may be available.

By signing up as a monthly donor today, your gifts will be invested in research at the Paul Albrechtsen Research Institute CancerCare Manitoba and will give Alyson hope for more tomorrows with her loved ones.

A cryostat is an essential piece of equipment which allows researchers to examine patients’ tissue samples with a high level of detail. Understanding these samples helps identify treatments based on the unique molecular make up of an individual’s cancer cells.

Your support today will allow for the purchase of a new and upgraded cryostat.

Your contribution toward this vital new equipment is an investment in those you love – and an investment in Alyson’s future. It is thanks to generous people like you that CancerCare Manitoba’s research program can bring innovative treatments to Manitobans. Treatments that save lives.

Alyson is grateful to donors like you.

 She is also grateful to the talented team of caregivers at CancerCare Manitoba who have helped her on her cancer journey. Today, she continues with regular scans and blood work to monitor the effectiveness of her treatment.

While her fear of the cancer spreading is very real, Alyson tries to stay positive through physical activity and spending time with loved ones. She also believes in the power of the research you help fund. In what it can do for her – and for so many Manitobans experiencing cancer.

Your gift matters.

Your investment today in a new and upgraded cryostat will help ensure that Manitobans like Alyson continue to have hope for more tomorrows with their loved ones.

Whether you make a one-time gift today or sign up as a monthly donor, you will make a real difference in the lives of Manitobans with cancer.

Bjorn’s Story – eNewsletter high

Bjorn is grateful for your support and the difference it has made in his life.

Thanks to donors’ incredible commitment to ensuring Manitobans with cancer have access to leading-edge care, Bjorn is living his best life surrounded and supported by the people he cares about most. This is something he does not take for granted given he has been diagnosed with cancer three times and undergone three life-saving surgeries in the last three years.

When he was just 27-years-old, Bjorn received the difficult news that he had testicular cancer. As a young, healthy, physically active person, the diagnosis was understandably surprising. Fortunately, Bjorn had been proactive with his health and went to see his doctor as soon as he suspected something was wrong.

Following scans and bloodwork, Bjorn was given a cancer diagnosis.

“That was on a Friday afternoon and less than a week later, I underwent surgery.” Bjorn is grateful for the quick action by 

20240216020

his oncology team at CancerCare Manitoba. “They always have a plan and that’s reassuring to me,” he said. After recovering from surgery, he was able to get back to doing things he loves – spending time with friends and family, exercising and returning to work as an accountant.

It was just nine months later following a routine scan that Bjorn’s oncologist detected cancer again. This time in the lymph nodes in his abdomen. Bjorn required complex abdominal surgery to remove the cancerous cells and hopefully prevent a future recurrence. Following surgery, in the height of the COVID-19 pandemic, Bjorn remained in hospital. Not being able to see his family was challenging and lonely. For the next couple of months, he allowed himself to enjoy the ‘down time’ to take care of his physical and mental health as he recovered.

Unfortunately, that was not Bjorn’s last surgery.

In January 2023 it was determined he would need a third surgery after a cancerous spot was found on one of his lungs.

Thanks to donor-funded advancements in cancer care, the procedure would be non-invasive and would directly target the cancerous cells, while preserving the remainder of his lungs. For this, Bjorn is extremely grateful to Manitobans like you who support cancer research.

Today, Bjorn is feeling positive about the future. In March of last year, two months after surgery and a day after his 30th birthday he received the positive news there were no areas of concern on his scans. While he is still being closely monitored 

by his care team at CancerCare Manitoba, the time between scans and appointments has grown. And overall, he’s feeling great.

Bjorn is committed to living a physically active lifestyle which he feels benefits his mental health as well. He plays a number of team sports and loves riding his bike.

This June, Bjorn will once again be walking in Challenge for Life as the co-captain of the Canada Life team. “I’ve participated in this event for many years, but since my diagnosis, it’s become closer to my heart, and more meaningful. I feel really supported by my friends and family who walk with me and donate to support a great cause.” 

Sylvia’s Story – eNewsletter high

You have been there for Sylvia, time and time again.

“I have stage four cancer but I’m still here,” says 80-year-old Sylvia who has been living with non-Hodgkin lymphoma since the year 2000. Thanks to donors’ investment in local cancer research, today Sylvia is thriving.

With her husband Gord by her side, Sylvia has been coming to CancerCare Manitoba for treatments for over 20 years. It hasn’t been an easy road. She has undergone intense chemotherapy treatments, experienced difficult side effects and allergic reactions and on more than one occasion, required blood transfusions to save her life. Still, she has remained positive and committed to living life to the fullest.

20240215437

In 2019, after almost 20 years of treatment, Sylvia’s chemotherapy stopped working. Sylvia and Gord were understandably anxious to find another treatment option. They were relieved to learn that thanks to years of donor-funded research, personalized approaches to treating cancer and blood disorders had advanced significantly. Advances in genomics and precision medicine gave them a renewed sense of hope.

Thanks to donor investment in research, new molecular tests were available that could help doctors understand the genetic makeup of the cancer cells in Sylvia’s body, creating the possibility for a new treatment option.

This testing led CancerCare Manitoba’s Dr. Versha Banerji to identify a novel treatment that targets the molecular makeup of the cancer cells in Sylvia’s body. As a result, today her cancer is being successfully treated through daily medication. And thankfully, she has few side effects.

Sylvia continues with regular visits to CancerCare for blood work to ensure that the cancer is still responding to the treatment. She is thankful for the amazing care she receives. “Everyone treats us so well at CancerCare Manitoba,” said Sylvia. “They are all like family to me now.”

She and Gord are grateful for the added years they have had together, after Gord’s own successful treatment for kidney cancer two years ago. Together they enjoy golfing, going out to their favourite restaurants with friends and attending concerts.

Sylvia’s life has been full and rich and with donors committed to cancer research in her corner, the future looks incredibly bright. For that, Sylvia and Gord are eternally grateful.

To honour the care they have both received, Sylvia and Gord joined the More Tomorrows Legacy Circle by including CancerCare Manitoba Foundation in their will. 

Click the image above to learn more about leaving a gift in your will.

World Cancer Day – Sara’s Story

World Cancer Day is held every February 4.
It is a global initiative raising awareness and improving education around cancer to evoke personal action.

Sara's Story

Thanks to donor generosity, education has helped many Manitobans become aware of the importance of self-screening for cancer. Sara is one of those Manitobans. 

A routine self-examination gave Sara cause for concern.

It was March of 2022 when Sara found a lump in her breast during a regular self-check. Having found lumps before that were found to be benign, she wasn’t overly concerned. Fortunately, though, she was concerned enough to visit her doctor – again. Just to be sure everything was okay.

Thinking the lump was suspicious, Sara’s doctor recommended an urgent mammogram.

That’s the day Sara’s life changed.

It was after the mammogram that I really started to become worried,” said Sara, “I was sent directly for an ultrasound and then told that I would need a biopsy. I was in shock and very upset.”

Only a few minutes later, while still reeling from the news of her impending biopsy, Sara received a phone call from her family doctor. She told Sara that she should prepare herself to hear the word ‘cancer.’ Not long after, the biopsy confirmed Sara’s worse fears: triple-negative invasive ductal carcinoma, an aggressive form of breast cancer.

By making a gift today, you will be supporting programs at CancerCare Manitoba that are critical to the early detection and successful treatment of many cancers.

Sara began treatment soon after her diagnosis. Over the next several months she would endure 16 rounds of chemotherapy. Sara experienced many negative side effects from the chemotherapy treatments including severe allergic reactions. Her dedicated care team regularly adjusted her treatment to ease her side effects while ensuring the cancer was still being successfully targeted.

Sara struggled with her mental health as she continued with the grueling treatments. Fortunately, she was able to access donor-funded emotional support services at CancerCare Manitoba.

“One of the most important things with cancer is your mental health,” said Sara. “Out of all of my amazing health-care providers, my therapist has been one of the most important people who have provided me with life-saving support.”

At the end of December, Sara completed chemotherapy. But her journey wasn’t over. She would still require surgery to fully remove the cancer and reduce her risk of its recurrence. Sara mentally prepared herself for surgery by exploring Manitoba for a month and spending time with the people she loves.

Sara’s journey is not over.

Sara’s surgery was successful and today she is cancer free. But her journey through recovery – both physically and mentally – is ongoing.

She continues with regular appointments at CancerCare Manitoba and is grateful for the donor-funded after-care programs that are helping her, including physical rehabilitation and mental health support.

For Sara, the fear of her cancer returning is very real, but she tries to focus on moving forward and is hopeful for what her future holds.

Sara’s story demonstrates how screening initiatives, including self-screening, are vital when it comes to early-detection and ultimately saving the lives of Manitobans.

If you are able to, we hope you will choose to support cancer screening and risk reduction initiatives this World Cancer Day, knowing your generosity will help others potentially detect their cancers early, giving them the best chance at successful treatment.

Our names are Hayley and Kevin, and the last year has been the hardest of our lives.

The strength and resilience of our daughter Ruby as she went through months of difficult cancer treatments is what has helped us get through this challenging time.

Donors’ generosity has improved Ruby’s chances of survival and given us more hope.

Donor’ support of research, clinical trials and enhanced treatments have led to new discoveries and has helped thousands of kids with cancer. Still, there are no guarantees for us. No guarantee for Ruby that her cancer will be cured forever and that she will have the opportunity to thrive.

We are sharing Ruby’s story with you today in hopes her strength and resilience inspire you to make a gift this holiday season. 

Ruby and her parents snuggle with fall trees in back.

It was one year ago that we first began to notice a change in Ruby’s behavior. She was lethargic, and not her usual, three-year-old, playful self. She has Down syndrome and is naturally quite happy most of time. We knew something wasn’t right as she struggled with a cough, fatigue and high fevers. It was a month filled with uncertainty and worry as we navigated multiple trips to the doctor, different medications and many visits to the emergency room. Then, a blood test at the hospital led to our world being turned upside down.

We were told that Ruby had cancer.

More tests were required to determine the type and severity of her cancer. Two days felt like an eternity as we waited for the diagnosis. Then, the doctor confirmed Ruby had acute myeloid leukemia, and laid out a rigorous, six-month chemotherapy treatment plan.

There is nothing that could have prepared us for how sick Ruby would become.

We were unprepared for how sick Ruby became as she endured her chemotherapy treatments. Before each cycle, she underwent a lumbar puncture, a painful procedure that requires children like Ruby to be sedated. She also underwent multiple bone marrow biopsies. Because these treatments were so intense, and Ruby had a risk of life-threatening infections, we had to stay in the hospital for weeks at a time. One of us would stay with Ruby during the daytime, and the other at night. It was challenging and we could both feel the toll it was taking on our mental health.

The support of people like you ensures that important programs at CancerCare Manitoba are available for families like ours during difficult times. Without access to therapy sessions, this year would have been very different for us. It’s hard to imagine how we would have gotten through it.

Ruby in pajamas in hospital room with blanket wrapped around her like a cape.

Ruby is so brave.

Overall, Ruby did well during the hospital stays. She was always smiling and cheerful, even on the toughest days. It was her strength that enabled us to be strong too. Then, as Ruby began her third cycle of chemotherapy, the unthinkable happened.

Ruby unexpectedly needed urgent life-saving care.

We were shocked when shortly after an infusion of chemotherapy, Ruby developed a terrible rash, began vomiting and was having difficulty breathing. Ruby was experiencing a severe life-threatening allergic reaction to the chemotherapy drugs. She was in anaphylactic shock. It took two shots of epinephrine before she responded and started breathing normally again.

Afterwards, we sat there, numb, watching her lie in the hospital bed. Seeing her hooked up to so many tubes and wearing an oxygen mask was terrifying. This experience only increased our fear that something devastating would happen to Ruby.

By donating monthly, your gift will help ensure that Ruby and other Manitoba kids with cancer receive the very best care, right here in our province.

Gifts from monthly donors are invested in local cancer research, and continued investment in research is needed so that when patients like Ruby experience serious complications, alternative treatments are available. We hope you will consider joining this loyal group with a monthly gift.

In mid-August after what felt like a lifetime, Ruby completed her chemotherapy treatment. After months and months of being in and out of the hospital we were desperate to return home but learned that it wouldn’t be possible. Ruby’s blood count was dangerously low due to her treatments. Weeks went by. Then, good news and instant tears from our entire family when we learned we could finally go home for good.

Ruby’s journey with cancer is far from over.

Each day Ruby requires three different medications to prevent infections. If Ruby were to get sick with a regular cold or other virus, it would be very dangerous. We’re worried that we’ll expose her to something simply from going to work each day.

We still have regular visits to CancerCare Manitoba where they continue to monitor Ruby. Every time she has a blood test, we are sick with anxiety as we wait for the results.

Ruby close up cuddle 1024x1024

Before Ruby became sick, she had just started walking on her own. Spending so much time in a hospital bed really set her back. But now, day by day, she’s starting to get stronger.

We are so proud of her and like every parent, we look forward to many future milestones in Ruby’s life. A life we hope will be free of cancer thanks to your kind support.

With you in our corner, we are optimistic for the future.

Your gifts ensure that Manitobans like our daughter have access to the best patient care and support programs right here in our province. Your thoughtful donation today will make a difference for our family, and we are so grateful.

Our deepest gratitude,

Hayley & Kevin

 

p.s. I am pleased to share with you a recorded webinar of Ruby’s doctor, Dr Ashley Chopek, speaking to the benefits of donor-funded research for people like Ruby with leukemia. You will also hear from me, Ruby’s mother, sharing my family’s personal experience.

 

Donation of Stocks, Bonds & Mutual Funds

A gift of marketable securities can be a tax-effective way for you to make a donation in support of Ruby. The tax on your investment’s capital gain (the difference between what you paid for the securities and their current value) is reduced to zero. This doubles the savings for you as there are no taxes on the capital gain and you receive a charitable tax receipt for the value of the securities, just as if you donated the equal amount in cash.

Securities eligible for gifting to CancerCare Manitoba Foundation are listed securities or publicly traded securities, which include:

  • Stocks and bonds
  • Treasury bills
  • Mutual funds offered by most Canadian mutual fund management companies

We recommend you submit the Securities Transfer Form no later than Friday, December 15 to your financial advisor to have your gift count toward this tax year.

For self-managed gifts of securities, we recommend you submit a Letter of Direction to your Financial Institution or Discount Broker.
Thank you for considering a gift in support of kids like Ruby. Your gift today may help discover new treatments for leukemias.

Giving Tuesday

This GivingTuesday your investment in cancer research made a difference.
 iA Financial Group matched donations up to $25,000.

The Paul Albrechtsen Research Institute CancerCare Manitoba is home to a unique set of single cell technologies. These technologies are allowing scientists to advance cancer research and develop new treatment options. At the root of developing new strategies to treat an individual’s type of cancer is understanding how individual cells interact with each other. This is why your investment in single cell technology is so critical.

Why Manitobans like Terri need your help.

What began as a routine doctor’s appointment led to multiple tests including ultrasounds and an urgent MRI. Ultimately, Terri was diagnosed with ovarian cancer in February of 2021 in the midst of the pandemic. 

After her diagnosis Terri was referred to a specialist and underwent major surgery within a month’s time. This was followed by six rounds of chemotherapy. Less than a year after her diagnosis, a CT scan thankfully showed no evidence of cancer.  Terri looked forward to returning to a more normal life.

The day before Terri was to return to work, she learned the cancer had returned. 

Although Terri felt healthy and was looking forward to returning to a job that she loved, she found herself once again preparing for rounds of chemotherapy. This time, the treatment took a heavier toll on her body and the side effects were more severe.

Mentally, it was also challenging. Her oncologist informed her that a recurrence in ovarian cancer is hard to treat with few treatment options that offer longevity. 

Research using single cell technology is critical for patients like Terri. With your help today, scientists at the Research Institute will be that much closer to creating individualized cancer treatment plans, changing the future of Manitobans like Terri impacted by a diagnosis.

“When you are given a diagnosis that doesn’t have a cure, it changes how you think. It’s very emotional.”

While Terri is symptom free today, it’s expected that one day, the cancer will return.  

Terri doesn’t know when her cancer will return. There are days anxiety and worry creep into her mind.

Despite all of this, Terri is living every day as fully as she can and trying not to worry about how many days she may have left. She makes very intentional choices about how she spends her time and does the things that matter to her the most. Like spending time with the people she loves, in particular her young grandsons.

“I’m still hoping they’ll have a lot of years to make memories with me and that they’re good memories.”

Join the movement and change the future.

This GivingTuesday we invite you to follow 17 Manitobans impacted by cancer who are sharing their stories in an effort to change the future – for you and for their loved ones.  Inspire others to join the movement. Share in your social media why cancer research is important to you using the hashtag #ForYourTomorrows.  

 

Follow a researcher who will turn your donation into life-saving treatments.

This GivingTuesday local researchers from the Paul Albrechtson Research Institute CancerCare Manitoba are sharing what your support means to them.  Follow them today to get a behind-the-scenes sense of the impact you have on them.

Learn more about single cell technology from local scientists in the Research Institute, Drs. Kirk McManus and Yale Michaels. 

Thank you to iA Financial Group for generously matching up to $25,000 in donations this GivingTuesday, helping Manitobans with cancer and their loved ones enjoy more tomorrows together. 

Thank you to iA Financial Group for generously matching up to $25,000 in donations this GivingTuesday, helping Manitobans with cancer and their loved ones enjoy more tomorrows together

Year-after-year, iA Financial Group makes a commitment to the community and works tirelessly to support its development and well-being.

iA Financial Group is one of the largest insurance and wealth management groups in Canada, with operations in the United States. Founded in 1892, it is an important Canadian public company and is listed on the Toronto Stock Exchange under the ticker symbols IAG (common shares) and IAF (preferred shares).

iA Financial Group’s objective is to provide support to causes that focus on improving quality of life for Canadians. They target donations to organizations working in the areas of health, education, social and community support, and the environment.

 

” At iA Financial Group, giving back to the communities in which we live and work is part of the core values of our corporate culture. 

We have family, friends and colleagues who have been impacted by a cancer diagnosis and as such we feel privileged to support a cause that impacts so many people. This GivingTuesday we matched all donations up to $25,000 to help support the life-saving work at CancerCare Manitoba.” 

– Azmina Karim-Bondy, Chair of the Corporate Donations Committee, Western Region 

L-R: James Crouch, Sales Director, iA Financial Group, Patti Smith, President & CEO, CancerCare Manitoba Foundation, Jessica Johanson, Sales Director, iA Financial Group, Ross Cook, Sales Director, iA Financial Group